Biodegradable Cationic Polymers for Nucleic Acid Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for delivering nucleic acids into cells face limitations such as toxicity and non-biodegradability, particularly with poly(ethylenimine) derivatives, which hinder effective gene therapy applications.
Innovation Solution
The development of cationic polymer units with polymeric arms, specifically poly(aspartic acid) derivatives like diethylenetriamine-modified aspartic acid, which form biodegradable complexes with nucleic acids through electrostatic interactions, enhancing transfection efficiency and reducing cytotoxicity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If poly(ethylenimine) derivatives are used for nucleic acid delivery, then transfection efficiency is improved, but cytotoxicity increases and biodegradability is lost
Solution Approach 1:
The patent changes the chemical composition parameters by replacing poly(ethylenimine) with poly(aspartic acid) derivatives, modifying the polymer structure to include biodegradable amide bonds while maintaining cationic properties through amine modification. This parameter change achieves both biodegradability and reduced cytotoxicity while preserving transfection efficiency
Solution Approach 2:
The invention creates a composite polymer structure by combining poly(aspartic acid) backbone with diethylenetriamine modifications, forming a new material class that integrates the biodegradability of natural polymers with the transfection capability of synthetic cationic polymers, thereby resolving the contradiction between efficiency and safety
2Productivity
If poly(ethylenimine) derivatives are used for nucleic acid delivery, then transfection efficiency is improved, but biodegradability is lost
Solution Approach 1:
The patent fundamentally changes the chemical composition from non-biodegradable poly(ethylenimine) to biodegradable poly(aspartic acid) derivatives, introducing hydrolyzable amide bonds in the polymer backbone that enable enzymatic and chemical degradation while maintaining the cationic properties necessary for nucleic acid complexation and delivery
Solution Approach 2:
The invention employs biodegradable polymers that are designed to be temporary and disposable in the biological system, degrading after fulfilling their delivery function, thereby eliminating long-term accumulation and toxicity issues associated with non-biodegradable poly(ethylenimine) while maintaining effective transfection
3Object-affected harmful factors
If existing non-viral gene carriers are used, then safety is improved compared to viral vectors, but transfection efficiency and biodegradability are compromised
Solution Approach 1:
The patent develops a composite polymer system combining the safety features of natural polymers (poly(aspartic acid) backbone) with the transfection efficiency of synthetic cationic polymers (diethylenetriamine modifications), creating a material that simultaneously achieves low toxicity and high transfection efficiency, overcoming the limitations of existing non-viral carriers
Solution Approach 2:
The invention applies local quality modification by keeping the poly(aspartic acid) backbone for biocompatibility and biodegradability while locally introducing diethylenetriamine modifications to provide cationic charge density necessary for effective nucleic acid complexation and cellular uptake, thereby achieving both safety and efficiency
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The biodegradable cationic polymer units effectively deliver nucleic acids into cells with low toxicity and high transfection efficiency, overcoming the limitations of existing non-viral gene carriers by providing a safer and more efficient gene delivery mechanism.
Implementation Method 1
form biodegradable complexes with nucleic acids through electrostatic interactions
Data Source
AI summary
In some embodiments, the present disclosure pertains to compositions for nucleic acid delivery into cells. In some embodiments, the composition comprises: (1) a cationic polymer unit comprising a plurality of polymeric arms, where the plurality of polymeric arms comprise poly(aspartic acid) derivatives; and (2) a nucleic acid associated with the cationic polymer unit. In some embodiments, the cationic polymer unit comprises a linker covalently associated with the plurality of polymeric arms. In some embodiments, the cationic polymer unit has a dendritic shape. In some embodiments, the cationic polymer unit has a star-like shape. In some embodiments, the cationic polymer unit is biodegradable. Further embodiments of the present disclosure pertain to methods of delivering a nucleic acid into cells by introducing into the cells one or more of the compositions of the present disclosure.